$ Medtecs Intl (546:SGX)
$0.112 -0.001 (-0.885%)
Analysed $ Medtecs Intl (546:SGX) News Sources
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
10-07-2026
yahoo.com
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
17-07-2026
yahoo.com
GM Just Posted Record First-Half Earnings, Recently Repurchased 35% of Its Shares, and Still Trades Below 6x Earnings
21-07-2026
247wallst.com
China’s rapid rise in drug development casts a long shadow over US oncology
24-07-2026
clinicaltrialsarena.com
Cardiac drug developer Braveheart banks more than $382M in IPO
05-08-2026
biopharmadive.com
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
17-08-2026
yahoo.com
Sandoz targets industry patent void with $322m Henlius deal
17-08-2026
pharmaceutical-technology.com
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
19-08-2026
yahoo.com
Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation, and Accelerating Progress Towards C-MNC
21-08-2026
yahoo.com
Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation
21-08-2026
yahoo.com
What is the current price of $ Medtecs Intl (546:SGX)?
The current price of $ Medtecs Intl (546:SGX) is $0.112.
$ Medtecs Intl (546:SGX) absolute price change since previous trading day?
The absolute price change of $ Medtecs Intl (546:SGX) since the previous trading day is $-0.001.
$ Medtecs Intl (546:SGX) percentage price change since previous trading day?
The percentage price change of $ Medtecs Intl (546:SGX) since the previous trading day is -0.885%.
What is the most recent average sentiment score for $ Medtecs Intl (546:SGX)?
The most recent average sentiment score for $ Medtecs Intl (546:SGX) is 70 out of 100.
What is the most recent average sentiment for $ Medtecs Intl (546:SGX)?
The most recent sentiment for $ Medtecs Intl (546:SGX) is .
SEC-8K** Filing Unavailable For $ Medtecs Intl (546:SGX)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.